These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 15459197)
1. Studies of the interaction of substituted mutants of BAX with yeast mitochondria reveal that the C-terminal hydrophobic alpha-helix is a second ART sequence and plays a role in the interaction with anti-apoptotic BCL-xL. Arokium H; Camougrand N; Vallette FM; Manon S J Biol Chem; 2004 Dec; 279(50):52566-73. PubMed ID: 15459197 [TBL] [Abstract][Full Text] [Related]
3. Bcl-XL protects BimEL-induced Bax conformational change and cytochrome C release independent of interacting with Bax or BimEL. Yamaguchi H; Wang HG J Biol Chem; 2002 Nov; 277(44):41604-12. PubMed ID: 12198137 [TBL] [Abstract][Full Text] [Related]
4. After embedding in membranes antiapoptotic Bcl-XL protein binds both Bcl-2 homology region 3 and helix 1 of proapoptotic Bax protein to inhibit apoptotic mitochondrial permeabilization. Ding J; Mooers BHM; Zhang Z; Kale J; Falcone D; McNichol J; Huang B; Zhang XC; Xing C; Andrews DW; Lin J J Biol Chem; 2014 Apr; 289(17):11873-11896. PubMed ID: 24616095 [TBL] [Abstract][Full Text] [Related]
5. The N-terminus and alpha-5, alpha-6 helices of the pro-apoptotic protein Bax, modulate functional interactions with the anti-apoptotic protein Bcl-xL. Parikh N; Koshy C; Dhayabaran V; Perumalsamy LR; Sowdhamini R; Sarin A BMC Cell Biol; 2007 May; 8():16. PubMed ID: 17519046 [TBL] [Abstract][Full Text] [Related]
6. The substitution of Proline 168 favors Bax oligomerization and stimulates its interaction with LUVs and mitochondria. Simonyan L; Légiot A; Lascu I; Durand G; Giraud MF; Gonzalez C; Manon S Biochim Biophys Acta Biomembr; 2017 Jun; 1859(6):1144-1155. PubMed ID: 28322731 [TBL] [Abstract][Full Text] [Related]
7. Distinct domains control the addressing and the insertion of Bax into mitochondria. Cartron PF; Arokium H; Oliver L; Meflah K; Manon S; Vallette FM J Biol Chem; 2005 Mar; 280(11):10587-98. PubMed ID: 15590655 [TBL] [Abstract][Full Text] [Related]
8. The substitution of the C-terminus of bax by that of bcl-xL does not affect its subcellular localization but abrogates its pro-apoptotic properties. Oliver L; Priault M; Tremblais K; LeCabellec M; Meflah K; Manon S; Vallette FM FEBS Lett; 2000 Dec; 487(2):161-5. PubMed ID: 11150501 [TBL] [Abstract][Full Text] [Related]
9. Structural biology of the Bcl-2 family of proteins. Petros AM; Olejniczak ET; Fesik SW Biochim Biophys Acta; 2004 Mar; 1644(2-3):83-94. PubMed ID: 14996493 [TBL] [Abstract][Full Text] [Related]
10. Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms. Minn AJ; Kettlun CS; Liang H; Kelekar A; Vander Heiden MG; Chang BS; Fesik SW; Fill M; Thompson CB EMBO J; 1999 Feb; 18(3):632-43. PubMed ID: 9927423 [TBL] [Abstract][Full Text] [Related]
11. Role of the C-terminal domain of Bax and Bcl-XL in their localization and function in yeast cells. Priault M; Camougrand N; Chaudhuri B; Manon S FEBS Lett; 1999 Jan; 443(2):225-8. PubMed ID: 9989610 [TBL] [Abstract][Full Text] [Related]
12. Bax and Bcl-xL independently regulate apoptotic changes of yeast mitochondria that require VDAC but not adenine nucleotide translocator. Shimizu S; Shinohara Y; Tsujimoto Y Oncogene; 2000 Sep; 19(38):4309-18. PubMed ID: 10980606 [TBL] [Abstract][Full Text] [Related]
13. Solution structure of human BCL-w: modulation of ligand binding by the C-terminal helix. Denisov AY; Madiraju MS; Chen G; Khadir A; Beauparlant P; Attardo G; Shore GC; Gehring K J Biol Chem; 2003 Jun; 278(23):21124-8. PubMed ID: 12651847 [TBL] [Abstract][Full Text] [Related]
14. Sequence and helicity requirements for the proapoptotic activity of Bax BH3 peptides. Shangary S; Oliver CL; Tillman TS; Cascio M; Johnson DE Mol Cancer Ther; 2004 Nov; 3(11):1343-54. PubMed ID: 15542773 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of Pro-apoptotic BAX by a noncanonical interaction mechanism. Barclay LA; Wales TE; Garner TP; Wachter F; Lee S; Guerra RM; Stewart ML; Braun CR; Bird GH; Gavathiotis E; Engen JR; Walensky LD Mol Cell; 2015 Mar; 57(5):873-886. PubMed ID: 25684204 [TBL] [Abstract][Full Text] [Related]
16. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4. Huang DC; Adams JM; Cory S EMBO J; 1998 Feb; 17(4):1029-39. PubMed ID: 9463381 [TBL] [Abstract][Full Text] [Related]
17. Investigation of bax-induced release of cytochrome c from yeast mitochondria permeability of mitochondrial membranes, role of VDAC and ATP requirement. Priault M; Chaudhuri B; Clow A; Camougrand N; Manon S Eur J Biochem; 1999 Mar; 260(3):684-91. PubMed ID: 10102996 [TBL] [Abstract][Full Text] [Related]
18. A brewing understanding of the regulation of Bax function by Bcl-xL and Bcl-2. Renault TT; Dejean LM; Manon S Mech Ageing Dev; 2017 Jan; 161(Pt B):201-210. PubMed ID: 27112371 [TBL] [Abstract][Full Text] [Related]
19. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations. Lama D; Sankararamakrishnan R Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209 [TBL] [Abstract][Full Text] [Related]
20. Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins. Ottilie S; Diaz JL; Horne W; Chang J; Wang Y; Wilson G; Chang S; Weeks S; Fritz LC; Oltersdorf T J Biol Chem; 1997 Dec; 272(49):30866-72. PubMed ID: 9388232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]